CIK 0001022899
- Non-accelerated filer
- Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061390025
- Phone
- +1 212-994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy Exec VP, Corporate Development bought 15,000 shares at an average $1.90 ($28,458)
- 4 Open-market buy Exec VP, Corporate Development bought 15,000 shares at an average $1.90 ($28,458)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Interim CFO gave up 9,718 shares (to pay taxes)
- 4 Other disposition Director disposed of 20,000 shares (other)
- 4 Other acquisition Director acquired 41,049 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 777,992 shares at an average $0.69 ($534,337)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 4 of 7 · 137 filings